Cargando…
SAT-LB002 Steroid Metabolome Analysis Reveals 11-Ketotestosterone as the Most Abundant Androgen in Castration-Resistant Prostate Cancer Patients on Second-Line Therapies
Introduction Metastatic castration-resistant prostate cancer (CRPC) remains a clinical challenge despite antitumoral therapies such as taxane chemotherapeutics, enzalutamide, and abiraterone acetate. Clinical studies have highlighted the benefits of these therapies on overall and progression-free su...
Autores principales: | Snaterse, Gido, van Dessel, Lisanne, Taylor, Angela, Visser, Jenny, Arlt, Wiebke, Lolkema, Martijn, Hofland, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551668/ http://dx.doi.org/10.1210/js.2019-SAT-LB002 |
Ejemplares similares
-
ODP435 11-Ketotestosterone is One of the Major Androgens in Pigs
por: Yazawa, Takashi, et al.
Publicado: (2022) -
SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer
por: Oksala, Riikka, et al.
Publicado: (2019) -
SAT-004 The Development And Application Of An Lc-ms/ms Method To Investigate The Stability Of 11β-hydroxyandrostenedione And 11-ketotestosterone.
por: Hawley, James
Publicado: (2019) -
11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration
por: Snaterse, Gido, et al.
Publicado: (2021) -
SAT-002 Measurement of Visceral Fat Using Computed Tomography in Two Subtypes of Primary Aldosteronism
por: Shibayama, Yui, et al.
Publicado: (2019)